Correlation Between Novartis and Straumann Holding

Can any of the company-specific risk be diversified away by investing in both Novartis and Straumann Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Straumann Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novartis AG and Straumann Holding AG, you can compare the effects of market volatilities on Novartis and Straumann Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Straumann Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Straumann Holding.

Diversification Opportunities for Novartis and Straumann Holding

0.78

Correlation Coefficient

Novartis  Straumann Holding

Poor diversification

The 3 months correlation between Novartis and Straumann is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG and Straumann Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Straumann Holding and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG are associated (or correlated) with Straumann Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Straumann Holding has no effect on the direction of Novartis i.e., Novartis and Straumann Holding go up and down completely randomly.

Pair Corralation between Novartis and Straumann Holding

Assuming the 90 days trading horizon Novartis AG is expected to under-perform the Straumann Holding. But the stock apears to be less risky and, when comparing its historical volatility, Novartis AG is 1.95 times less risky than Straumann Holding. The stock trades about -0.16 of its potential returns per unit of risk. The Straumann Holding AG is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  11,890  in Straumann Holding AG on September 12, 2024 and sell it today you would lose (175.00) from holding Straumann Holding AG or give up 1.47% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Novartis AG  vs.  Straumann Holding AG

Novartis AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novartis AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Straumann Holding

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Straumann Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Straumann Holding is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Novartis and Straumann Holding

The main advantage of trading using opposite Novartis and Straumann Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Straumann Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Straumann Holding will offset losses from the drop in Straumann Holding's long position.

The idea behind Novartis AG and Straumann Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.